To continue to develop our position as an international, high margin, cash generative, specialist Veterinary Pharmaceuticals and related products business with clear focus on key therapeutic areas.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company